Author

Jaclynn Campos

Institutions: Mayo Clinic, Mayo Clinic in Florida

Observed institutions: Mayo Clinic, Mayo Clinic in Florida

OpenAlex ID: A5139575813

Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax—an analysis from the International Consortium for MDS (icMDS) VALIDATE database

2026 · Jan Philipp Bewersdorf, Tariq Kewan, et al. · Blood Cancer Journal · 3

Validation of the International Working Group 2023 response criteria for higher risk myelodysplastic syndromes/neoplasms using the International Consortium for Myelodysplastic Syndromes VALIDATE database and a randomized phase III trial

2026 · Jan Philipp Bewersdorf, Tariq Kewan, et al. · Haematologica

Works count: 2

Citation count: 2

H-index: 1

I10-index: